Palomar (PLMR) Earnings Expected to Grow: Should You Buy?

Palomar (PLMR) is expected to post significant year-over-year growth for the quarter ended June 2025, with consensus estimates at $1.68 EPS (+34.4%) and $186.21 million in revenue (+42.1%). Analyst sentiment has recently turned more bullish, evidenced by a 2.41% upward revision in consensus EPS over the past 30 days. This, combined with a positive Zacks Earnings ESP of +0.25% and a Zacks Rank #2 (Buy), positions Palomar as a compelling candidate to beat consensus EPS estimates, aligning with its consistent track record of surpassing expectations in the last four quarters.

Analysis

Palomar Holdings (PLMR) is positioned for a strong upcoming earnings report for the quarter ended June 2025, with consensus estimates pointing to substantial year-over-year growth. Wall Street anticipates a 34.4% increase in earnings per share to $1.68 and a 42.1% rise in revenue to $186.21 million. Analyst sentiment has trended positive, reflected by a 2.41% upward revision in the consensus EPS estimate over the past 30 days. This bullish outlook is further substantiated by the company's proprietary metrics; a positive Zacks Earnings ESP of +0.25% combined with a Zacks Rank of #2 (Buy) indicates a high statistical probability of an earnings beat. This aligns with Palomar's consistent track record of surpassing consensus EPS estimates for the last four consecutive quarters, including a notable +17.61% surprise in the prior quarter. In contrast, while peer Allstate (ALL) also expects strong YoY earnings growth, its downward estimate revisions and negative ESP create a more uncertain pre-earnings outlook, highlighting Palomar's comparatively stronger position based on these predictive indicators.

Key Decisions for Investors

• Given the combination of strong growth forecasts, positive analyst revisions, and a high probability of an earnings beat, investors could view the current setup as a potential positive catalyst for Palomar's stock.
• While the pre-earnings indicators are favorable, price action will ultimately depend on the actual results and management's forward guidance; therefore, it is critical to monitor the earnings call for commentary on the sustainability of growth.
• The divergence in predictive metrics between Palomar (positive ESP, upward revisions) and its peer Allstate (negative ESP, downward revisions) may present a potential pair-trade opportunity for investors looking to capitalize on relative sector performance.